ECTRIN Erdosteine 175mg / 5mL Powder for Suspension 60mL
RXDRUG-DR-XY30165-60
Discreet Packaging
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
FDA-registered Products
FDA-licensed Pharmacies
Features
Brand
Ectrin
Full Details
Dosage Strength
175mg / 5ml
Drug Ingredients
- Erdosteine
Drug Packaging
Powder for Suspension 60ml
Generic Name
Erdosteine
Dosage Form
Powder For Suspension
Registration Number
DR-XY30165
Drug Classification
Prescription Drug (RX)
Description
Indications/Uses
Treatment of acute bronchitis, chronic bronchitis and its exacerbations. Respiratory disorders characterized by abnormal bronchial secretions and impaired mucus transport.
Dosage/Direction for Use
Capsule: 1 cap 2-3 times daily.
Suspension: Adults and Children >30 kg: 10 mL (2 tsp) twice daily.
Children 20-30 kg: 5 mL (1 tsp) 3 times a day; 15-19 kg: 5 mL (1 tsp) twice daily.
Direction for Reconstitution: To make 60 mL suspension: Add 42 mL of water and shake well until all the powder are evenly suspended.
To make 100 mL suspension: Add 70 mL of water and shake well until all the powder are evenly suspended.
Suspension: Adults and Children >30 kg: 10 mL (2 tsp) twice daily.
Children 20-30 kg: 5 mL (1 tsp) 3 times a day; 15-19 kg: 5 mL (1 tsp) twice daily.
Direction for Reconstitution: To make 60 mL suspension: Add 42 mL of water and shake well until all the powder are evenly suspended.
To make 100 mL suspension: Add 70 mL of water and shake well until all the powder are evenly suspended.
Overdosage
With dosages exceeding the recommended dose (1200 mg/day), sweating, vertigo and flushing have been observed.
Administration
May be taken with or without food.
Contraindications
Known hypersensitivity to erdosteine. Because of a possible interference of erdosteine metabolites with the methionine metabolism, erdosteine is contraindicated in patients suffering from hepatic cirrhosis and deficiency of the cystathionine-synthetase enzyme.
Suspension: Phenylketonuria, due to the presence of aspartame.
Suspension: Phenylketonuria, due to the presence of aspartame.
Special Precautions
Effects on the Ability to Drive or Operate Machinery: No effects have been reported.
Use in pregnancy & lactation: The safety of erdosteine during human pregnancy has not been established and therefore, as with all other new drugs, its use is not recommended. Ectrin is also not recommended during lactation.
Use in pregnancy & lactation: The safety of erdosteine during human pregnancy has not been established and therefore, as with all other new drugs, its use is not recommended. Ectrin is also not recommended during lactation.
Use In Pregnancy & Lactation
The safety of erdosteine during human pregnancy has not been established and therefore, as with all other new drugs, its use is not recommended. Ectrin is also not recommended during lactation.
Storage
Store at a temperature not exceeding 30°C. Protect from light.
The reconstituted suspension is stable for 1 week (7 days) at temperatures not exceeding 30°C (room temperature) and 2 weeks (14 days) at 2-8°C temperature (refrigerated).
The reconstituted suspension is stable for 1 week (7 days) at temperatures not exceeding 30°C (room temperature) and 2 weeks (14 days) at 2-8°C temperature (refrigerated).
Action
Pharmacokinetics: Peak plasma levels are reached after 30-60 min. Ectrin has subsequent complete metabolism in similar metabolites.
MedsGo Class
Cough & Cold Preparations
Please sign in so that we can notify you about a reply